The Value of Radiotherapy in Patients With Resectable Stage IIIA Non–Small-Cell Lung Cancer in the Era of Individualized Treatment: A Population-Based Analysis-Reference-Cited by-同舟云学术

The Value of Radiotherapy in Patients With Resectable Stage IIIA Non–Small-Cell Lung Cancer in the Era of Individualized Treatment: A Population-Based Analysis

Published:2023-01 Issue:1 Volume:24 Page:18-28
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Liu Bohao,Wang Zhiyu,Zhao Heng,Gao Shan,Wang Hongyi,Zhang Yanpeng,Fan Kun,Tao Runyi,Li Yixing,Feng Jinteng,Sun Yuchen,Zhang Jia,Zhang Guangjian

Funder

Key Science and Technology Program of Shaanxi Province

Key Research and Development Projects of Shaanxi Province

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference47 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Interdisciplinary multimodality management of stage III nonsmall cell lung cancer;Huber;Eur Respir Rev,2019

3. Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America;Veeramachaneni;Ann Thorac Surg,2012

4. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer;Forde;N Engl J Med,2022

5. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data;Sarah;Lancet,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on non-small cell lung cancer;Vacunas (English Edition);2024-04

2. A review on non-small cell lung cancer;Vacunas;2024-04

3. A novel nomogram to identify the III-N2 non-small cell lung cancer patients who may benefit from adjuvant radiotherapy;2023-07-27

4. The Valuable Prognostic Impact of Regional Lymph Node Removed on Outcomes for IIIA N0 NSCLC Patients;Journal of Cancer;2023